Compile Data Set for Download or QSAR
Report error Found 263 Enz. Inhib. hit(s) with all data for entry = 10931
TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579449BDBM579449(US11479560, Title ARN-1-770 | US11479560, Title AR...)
Affinity DataEC50: >500nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579287BDBM579287(US11479560, Title KM-4-173-3)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579290BDBM579290(US11479560, Title KM-4-182-2)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579296BDBM579296(US11479560, Title KM-4-207-1)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579271BDBM579271(US11479560, Title ww6-56 | US11479560, Title ww6-6...)
Affinity DataEC50: <1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579271BDBM579271(US11479560, Title ww6-56 | US11479560, Title ww6-6...)
Affinity DataEC50: <1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579269BDBM579269(US11479560, Title ww6-39)
Affinity DataEC50: <1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579270BDBM579270(US11479560, Title ww6-40)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579276BDBM579276(US11479560, Title DM-27)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579277BDBM579277(US11479560, Title DM-29)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579319BDBM579319(US11479560, Title ww6-266 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579320BDBM579320(US11479560, Title ww6-268-first)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579319BDBM579319(US11479560, Title ww6-266 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579322BDBM579322(US11479560, Title ww6-272 | US11479560, Title ww6-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579327BDBM579327(US11479560, Title ww6-308 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579326BDBM579326(US11479560, Title ww6-306 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579298BDBM579298(US11479560, Title KM-4-209-1)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579308BDBM579308(US11479560, Title KM-4-289)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579312BDBM579312(US11479560, Title ww6-130)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579309BDBM579309(US11479560, Title ww6-90)
Affinity DataEC50: <1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579351BDBM579351(US11479560, Title WZ-II-104)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579349BDBM579349(US11479560, Title WZ-II-93)
Affinity DataEC50: <1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579354BDBM579354(US11479560, Title WZ-II-149 | US11479560, Title WZ...)
Affinity DataEC50: <1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579359BDBM579359(US11479560, Title WZ-II-184-2)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579360BDBM579360(US11479560, Title WZ-II-186 | US11479560, Title WZ...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579358BDBM579358(US11479560, Title WZ-II-184-1)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579319BDBM579319(US11479560, Title ww6-266 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579319BDBM579319(US11479560, Title ww6-266 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579319BDBM579319(US11479560, Title ww6-266 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579319BDBM579319(US11479560, Title ww6-266 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579337BDBM579337(US11479560, Title WZ-I-190-2)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579343BDBM579343(US11479560, Title WZ-I-300)
Affinity DataEC50: <1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579344BDBM579344(US11479560, Title WZ-I-310)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579341BDBM579341(US11479560, Title WZ-I-283)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579342BDBM579342(US11479560, Title WZ-I-298)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579379BDBM579379(US11479560, Title ARN-1-85 | US11479560, Title ARN...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579379BDBM579379(US11479560, Title ARN-1-85 | US11479560, Title ARN...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579376BDBM579376(US11479560, Title WZ-III-10 | US11479560, Title WZ...)
Affinity DataEC50: <1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579378BDBM579378(US11479560, Title ARN-1-28)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579383BDBM579383(US11479560, Title ARN-1-223)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579381BDBM579381(US11479560, Title ARN-1-163)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579382BDBM579382(US11479560, Title ARN-1-212)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579387BDBM579387(US11479560, Title ARN-1-255)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579385BDBM579385(US11479560, Title ARN-1-238)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579386BDBM579386(US11479560, Title ARN-1-243)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579391BDBM579391(US11479560, Title ARN-1-269)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579392BDBM579392(US11479560, Title ARN-1-284)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579390BDBM579390(US11479560, Title ARN-1-267)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579360BDBM579360(US11479560, Title WZ-II-186 | US11479560, Title WZ...)
Affinity DataEC50: <1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 579367BDBM579367(US11479560, Title WZ-II-208-2 | US11479560, Title ...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Displayed 1 to 50 (of 263 total ) | Next | Last >>
Jump to: